Search for

 

1234 results found

Your Society: Reflections and looking forward

As November draws to a close, I’ve been reflecting on how quickly this year at the Society has passed. It has been a busy, fruitful year - from returning to in-person meetings to developing exciting new projects that we’ll continue to work on in 2023 – and I’m thankful to our...

Joint statement: letter on the regulation of medicines from the Secretaries of State for Heath and I

The Academy of Medical Royal Colleges and the British Pharmacological Society welcome the letter from the Secretaries of State for Heath and Industry to the Financial Times on 4 July, titled “The UK wants to continue to work with the EU on medicines” .   We have been c...

Professor Jennifer Martin appointed new Editor-in-Chief of Pharmacology Research & Perspectives (PR&

Professor Jennifer Martin, new Editor-in-Chief of PR&P from January 2024. We are pleased to announce that Professor Jennifer Martin has been appointed as the next Editor-in-Chief of Pharmacology Research & Perspectives (PR&P) , the open-access journal co-owned by th...

The BPS at ERNEST, Belfast 2019

In October 2019, I had the absolute privilege of attending the European Research Network on Signal Transduction (ERNEST) meeting in Belfast on behalf of the British Pharmacological Society (BPS). This was its inaugural meeting, with a focus on ‘GPCR Pharmacology: Activation, ...

Pharmacogenomics in Drug Development

The British Pharmacological Society and the UK Pharmacogenetics and Stratified Medicine Network are hosting a joint virtual meeting on ‘Pharmacogenomics in Drug Development’, hosted by Professor Sir Pirmohamed.

eLearning Project Coordinator

The British Pharmacological Society is recruiting for an eLearning Project Coordinator Salary: Grade F, Steps 1-3, (£36,558 - £38,785) What does the role involve? This is an exciting opportunity to lead the development of an innovative eLearning platform and training...

Contact us

Contact us As a global community, we always want to hear from our members, the science community and wider public. We're happy to answer any questions you might have, and encourage you to let us know about any exciting projects you have going on! Get in touch The easie...

Bispecific Antibody Rybrevant®▼ (amivantamab) awarded Drug Discovery of the Year 2023

The team behind the development of the lung cancer treatment Rybrevant®▼ (amivantamab) has been awarded Drug Discovery of the Year 2023, the British Pharmacological Society’s prestigious annual award. Amivantamab blocks signals that grow cancer cells and also attracts i...

2023 Fellows and Honorary Fellows

The British Pharmacological Society is delighted to announce our new Fellows and Honorary Fellows for 2023. The Society has elected 29 Fellows and awarded nine Honorary Fellowships. Our Fellows and Honorary Fellows play an incredibly important role in the Society. Through t...

Financial statements​

Download a PDF of the British Pharmacological Society’s financial statements for the year ended 31 December 2023. The financial statements include the Financial Review, Statement of Financial Activities and Balance Sheet, together with the Notes to the Accounts. They s...